stars 1 stars 2 stars 3

Telormedix SA is a Swiss-based biopharmaceutical company formed to develop immuno-selective drugs for the treatment of cancer and other diseases. We will initially focus on drugs that have been previously tested in humans and have favorable safety profile. This approach will allow us to rapidly develop drugs designed to be concomitantly very selective and well tolerated.

Telormedix Questions

The Telormedix annual revenue was $1 million in 2026.

Telormedix is based in Bioggio, Ticino.

The NAICS codes for Telormedix are [32, 32541, 325, 3254].

The SIC codes for Telormedix are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users